(NASDAQ:SUNS), WEST PALM BEACH, Fla., Jan. 28, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), an institutional lender that originates and funds loans to commercial real estate projects in the Southern U.S., announced the pricing on January 27, 2025, of its upsized underwritten public offering (the “Offering”) of 5,750,000 […]
(NasdaqGM:CCLD),(NasdaqGM:CCLDP),(NasdaqGM:CCLDO), Somerset, NJ, Jan. 28, 2025 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference
(CNSX:ACT.CN),(OTC US:ACTHF),(Other OTC:ACTHF),(Boerse Frankfurt – Freiverkehr:9D5),(NASDAQ:ADUR), LONDON, Ontario, Jan. 28, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st
CAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) — Walden Biosciences, Inc. (“Walden”), a private, venture-backed biotechnology company advancing disease-modifying therapies to transform the treatment of kidney disease, today announced the appointment of Howard Mayer, M.D. to its Board of Directors. “Howard is an accomplished leader in the biopharmaceutical industry, and we are pleased to welcome
CHICAGO, Jan. 28, 2025 (GLOBE NEWSWIRE) — Amplify ETFs announces the realignment of its cannabis ETFs to provide investors with dynamic exposure to the cannabis industry. On January 28, 2025, the Amplify Seymour Cannabis ETF (CNBS) will change its investment policy to invest in securities of U.S. companies engaged in cannabis and hemp-related activities. In
(NasdaqGM:SABS),(NasdaqGM:SABSW), SAB-142 was generally well-tolerated among healthy volunteers; data from Phase 1 trial confirms SAB-142 does not cause serum sickness or anti-drug antibodies at target dose Study results support that SAB-142 is well-positioned for re-dosing in outpatient setting for type 1 diabetes Results will be presented in an R&D webinar event today at 8:00 am
(NASDAQ:RVYL), SAN DIEGO, CA, Jan. 28, 2025 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”), a leading innovator of payment transaction solutions leveraging electronic payment technology for diverse international markets, has paid the initial tranche of $13.0 million to a securityholder of the Company on January 27, 2025, which completed the following:
(NYSE:COLD),(TSX:CP),(NYSE:CP), ATLANTA, GA., Jan. 28, 2025 (GLOBE NEWSWIRE) — Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition, and development of temperature-controlled warehouses, today announced plans to develop its first Import-Export Hub in Canada at Port Saint John in New Brunswick. This
(NASDAQ:CCBG), TALLAHASSEE, Fla., Jan. 28, 2025 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $13.1 million, or $0.77 per diluted share, for the fourth quarter of 2024 compared to $13.1 million, or $0.77 per diluted share, for the third quarter of 2024, and $11.7
(TSX:ISC),(TSX:ISV), Sustained organic revenue and adjusted EBITDA growth forecasted in 2025. Robust free cash flow will support growth and further deleveraging of the balance sheet. Focus on M&A and business development in 2025 in support of 2028 growth goals. REGINA, Saskatchewan, Jan. 28, 2025 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISC) (“ISC”, “we” or the